NewTimeSpace News: Lead Intelligent Equipment (00470.HK) closed its public offer at noon today (February 6). Preliminary market statistics show that the total margin financing for the public offering tranche reached approximately HK$21.833 billion, compared with the public offering fund size of HK$429 million, representing an oversubscription rate of approximately 49.92 times.
NewTimeSpace News: Zhejiang Rongtai Electric Material Co., Ltd. (603119.SH) officially submitted a listing application to the Stock Exchange of Hong Kong Limited on January 29, 2026, with CITIC Securities serving as the sole sponsor. According to a Frost & Sullivan report, the company ranked first in the global mica product market for the new energy sector with a 22.6% market share in terms of 2024 operating revenue.
NewTimeSpace News: The Hong Kong IPO subscription for Eastroc Beverage (Group) Co., Ltd. (09980.HK) is set to close tomorrow (January 29). The company's maximum offer price for this issuance is HK$248 per share, with an entry fee of approximately HK$25,050.11 per board lot. As per the latest statistics, the total margin financing capital received amounts to HK$11.751 billion.
NewTimeSpace News: According to information released by the Stock Exchange of Hong Kong Limited (HKEX), Shenzhen Woer Heat-Shrinkable Material Co., Ltd. (002130.SZ) passed the listing hearing of HKEX on January 27. China Securities Co., Ltd. International and China Merchants Securities Co., Ltd. International serve as joint sponsors. A global leader in the heat-shrinkable materials industry, the Company held a 20.6% global market share in 2024. It also ranks as the world's third-largest telecom cable manufacturer and China's largest high-speed copper cable manufacturer.
PrimeGenX Therapeutics Co., Ltd. formally submitted an application to list on the Main Board of The Stock Exchange of Hong Kong Limited on January 21, 2026, with CITIC Securities and CMBC Capital acting as joint sponsors. The company is a biotech firm specializing in the immune-inflammation field. Its core strategy is to develop differentiated therapies for chronic inflammatory diseases through innovative design and precise local delivery technologies. Its key late-stage core product is PuMeiXiTiNi (PG-011) for treating atopic dermatitis and allergic rhinitis.
Busy Ming Group Co., Ltd. (01768.HK) officially launched its initial public offering (IPO) on January 20, 2026. The offering price is set in the range of HK$229.6 to HK$236.6 per share, with a maximum expected fundraising amount of approximately HK$3.336 billion.Leveraging its discount retail model and full franchise system, the company has expanded its store network rapidly from around 6,585 to nearly 20,000 in less than two years, among which approximately 59% are located in the sinking market, cementing its position as the industry leader. Its financials have registered exponential growth, with revenue hitting RMB 39.344 billion in 2024.This IPO has garnered strong backing from eight top-tier cornerstone investors including Tencent, Temasek, BlackRock and Fidelity, with a combined subscription of approximately HK$1.52 billion.
The public offering of MiniMax (00100.HK) is scheduled to close at 12:00 noon today (January 6). Data shows that the public offering tranche has recorded an over-subscription rate of around 1,350.75 times, with margin financing funds reaching approximately HK$283.143 billion. The company is expected to be listed on the Main Board of the Hong Kong Stock Exchange on January 9.
As of 10:46 on January 6, 2026, Communication ETF (515880) fell 2.29%, with the latest quote at 3.07 yuan.
Beijing Roborock Technology has obtained CSRC filing approval for its proposed Hong Kong IPO of up to 33,108,000 shares. The filing is valid for 12 months, requires reporting of material events and post-listing details within 15 working days, and does not represent CSRC's endorsement of investment value or accuracy of materials.
Shaanxi Tourism Culture Industry Co., Ltd. will be listed on the Shanghai Main Board on January 6, 2026, with an issue price of RMB 80.44 per share. As a Shaanxi provincial state-owned assets-controlled cultural tourism enterprise, the company's core revenue comes from the renowned performance project "The Song of Everlasting Regret". The funds raised from this listing will be used for project acquisitions and the expansion of its performance model replication in other regions.
EVE Energy Co., Ltd. (300014.SZ) formally submitted an application for a main board listing on the Hong Kong Stock Exchange on January 2, with CITIC Securities acting as the sole sponsor. The company is one of the few globally integrated lithium battery platform enterprises covering consumer, power, and energy storage batteries across all application scenarios. In 2024, it ranked second globally in energy storage battery shipments, while also maintaining leading positions in the consumer and power battery sectors.
On December 30, 2025, Insilico Medicine, hailed as "the first AI-driven pharmaceutical stock on the Hong Kong stock market" and a strategic investment of the Hong Kong Investment Corporation Limited (HKIC), was listed on the Main Board of the Hong Kong Exchanges and Clearing Limited (HKEX). With a total fundraising of HK$2.277 billion, it has claimed the title of the largest IPO in the biopharmaceutical sector of the Hong Kong stock market in 2025, and its share price delivered an impressive performance on the debut day. It is reported that Biren Technology, another portfolio company of HKIC, is also set to list on the HKEX on January 2, 2026, which indicates that the effectiveness of HKIC’s diversified strategic investment layout continues to unfold.
